Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “New York”

Study to Assess Safety, Pharmacokinetics, and Treatment Effect of CabtreoRecruiting
NCT07524946Phase 4Updated Jul 29, 2026
Sponsor: Bausch Health Americas, Inc.
Acne Vulgaris
United States
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid TumorsRecruiting
NCT03526835Phase 1, Phase 2Updated Jul 29, 2026
Sponsor: Merus B.V.
Advanced/Metastatic Solid Tumors · Colorectal Cancer · Gastric Cancer · Gastroesophageal-junction Cancer
United States, Belgium, France, Italy, Netherlands +2 more
Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus ErythematosusCompleted
NCT03742037Phase 2Updated Jul 29, 2026
Sponsor: Viatris Innovation GmbH
Systemic Lupus Erythematosus
United States, Bulgaria, Chile, Czechia, France +19 more
ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and InflammationCompleted
NCT05021835Phase 3Updated Jul 28, 2026
Sponsor: Novo Nordisk A/S
Cardiovascular Risk · Chronic Kidney Disease · Inflammation
United States, Argentina, Australia, Belgium, Brazil +33 more
Frequency of Selected Single Nucleotide Polymorphisms in Huntington Disease Gene Expansion CarriersCompleted
NCT06667414N/AUpdated Jul 28, 2026
Sponsor: Hoffmann-La Roche
Huntington Disease
United States, Argentina, Australia, Canada, Denmark +7 more
Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia AActive Not Recruiting
NCT04644575Phase 3Updated Jul 28, 2026
Sponsor: Bioverativ, a Sanofi company
Hemophilia A
United States, Argentina, Australia, Belgium, Brazil +18 more
Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases NetworkRecruiting
NCT02450851N/AUpdated Jul 28, 2026
Sponsor: National Human Genome Research Institute (NHGRI)
Genetic Disease
United States
A Study to Test Whether Different Doses of BI 1291583 Help People With BronchiectasisCompleted
NCT05238675Phase 2Updated Jul 28, 2026
Sponsor: Boehringer Ingelheim
Bronchiectasis
United States, Australia, Belgium, Bulgaria, Canada +18 more
A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard TreatmentRecruiting
NCT07036523Phase 2Updated Jul 28, 2026
Sponsor: Boehringer Ingelheim
Idiopathic Pulmonary Fibrosis
United States, Australia, Belgium, Canada, Germany +5 more
Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic MedicationsRecruiting
NCT07565428Phase 3Updated Jul 28, 2026
Sponsor: Minerva Neurosciences
Negative Symptoms of Schizophrenia
United States
Danon Disease Natural History StudyRecruiting
NCT06214507N/AUpdated Jul 28, 2026
Sponsor: Rocket Pharmaceuticals Inc.
Danon Disease
United States, Germany, Israel, Italy, Spain +1 more
Phase III Study of AK112 for NSCLC PatientsActive Not Recruiting
NCT06396065Phase 3Updated Jul 28, 2026
Sponsor: Summit Therapeutics
Non-Squamous Non-small Cell Lung Cancer
United States, Canada, France, Italy, Spain +1 more
Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular FunctionActive Not Recruiting
NCT04763200NAUpdated Jul 28, 2026
Sponsor: Abiomed Inc.
Left Ventricular Dysfunction · Coronary Artery Disease
United States, Canada, Germany, Italy, Netherlands +2 more
SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic LymphomaActive Not Recruiting
NCT01574274Phase 2Updated Jul 28, 2026
Sponsor: Dana-Farber Cancer Institute
Acute Lymphoblastic Leukemia · Lymphoblastic Lymphoma
United States, Canada
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic ValvesRecruiting
NCT05172973NAUpdated Jul 27, 2026
Sponsor: Edwards Lifesciences
Aortic Valve Insufficiency · Aortic Valve Stenosis
United States, Canada
Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial CancersActive Not Recruiting
NCT05538897Phase 1, Phase 2Updated Jul 27, 2026
Sponsor: National Cancer Institute (NCI)
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma · FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma · Metastatic Endometrial Endometrioid Adenocarcinoma · Recurrent Endometrial Endometrioid Adenocarcinoma
United States
Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant ChemotherapyActive Not Recruiting
NCT02445391Phase 3Updated Jul 27, 2026
Sponsor: ECOG-ACRIN Cancer Research Group
Estrogen Receptor Negative · HER2/Neu Negative · Invasive Breast Carcinoma · Progesterone Receptor Negative
United States, South Africa
ADVENT Post Approval StudyActive Not Recruiting
NCT06431815N/AUpdated Jul 27, 2026
Sponsor: Boston Scientific Corporation
Paroxysmal Atrial Fibrillation
United States, Brazil, Canada, Chile
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic MutationRecruiting
NCT06647498Phase 2, Phase 3Updated Jul 27, 2026
Sponsor: Washington University School of Medicine
Alzheimers Disease · Dementia · Alzheimers Disease, Familial
United States, Argentina, Australia, Canada, Colombia +10 more
Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell DiseaseRecruiting
NCT02675959Phase 2Updated Jul 27, 2026
Sponsor: New York Medical College
Sickle Cell Disease
United States
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary DiseaseRecruiting
NCT07363694Phase 2, Phase 3Updated Jul 27, 2026
Sponsor: Pfizer
Moderate to Severe Chronic Obstructive Pulmonary Disease
United States, Argentina, Canada, China, India +3 more
VE303 for Prevention of Recurrent Clostridioides Difficile InfectionRecruiting
NCT06237452Phase 3Updated Jul 27, 2026
Sponsor: Vedanta Biosciences, Inc.
Clostridium Difficile · Clostridium Difficile Infections · Clostridium Difficile Infection Recurrence · Clostridioides Difficile Infection
United States, Australia, Belgium, Brazil, Bulgaria +19 more
Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)Active Not Recruiting
NCT04816604Phase 2Updated Jul 27, 2026
Sponsor: Gossamer Bio USA, Inc.
Pulmonary Arterial Hypertension
United States, Australia, Czechia, France, Germany +2 more
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)Recruiting
NCT06395103Phase 1, Phase 2Updated Jul 27, 2026
Sponsor: Merck Sharp & Dohme LLC
B-cell Acute Lymphoblastic Leukemia · Diffuse Large B-cell Lymphoma · Burkitt Lymphoma · Neuroblastoma
United States, Australia, Belgium, Brazil, Canada +18 more
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic MutationRecruiting
NCT05552157Phase 2, Phase 3Updated Jul 27, 2026
Sponsor: Washington University School of Medicine
Alzheimers Disease · Dementia · Alzheimers Disease, Familial
United States, Argentina, Australia, Canada, Colombia +10 more

Previous page Next page